# § 493.1800   Basis and scope.

(a) *Statutory basis.* (1) Section 1846 of the Act—


(i) Provides for intermediate sanctions that may be imposed on laboratories that perform clinical diagnostic tests on human specimens when those laboratories are found to be out of compliance with one or more of the conditions for Medicare coverage of their services; and


(ii) Requires the Secretary to develop and implement a range of such sanctions, including four that are specified in the statute.


(2) The Clinical Laboratory Improvement Act of 1967 (section 353 of the Public Health Service Act) as amended by CLIA 1988, as amended by section 2 of the Taking Essential Steps for Testing Act of 2012—


(i) Establishes requirements for all laboratories that perform clinical diagnostic tests on human specimens;


(ii) Requires a Federal certification scheme to be applied to all such laboratories; and


(iii) Grants the Secretary broad enforcement authority, including—


(A) Use of intermediate sanctions;


(B) Suspension, limitation, or revocation of the certificate of a laboratory that is out of compliance with one or more requirements for a certificate; and


(C) Civil suit to enjoin any laboratory activity that constitutes a significant hazard to the public health.


(3) Section 353 also—


(i) Provides for imprisonment or fine for any person convicted of intentional violation of CLIA requirements;


(ii) Specifies the administrative hearing and judicial review rights of a laboratory that is sanctioned under CLIA; and


(iii) Requires the Secretary to publish annually a list of all laboratories that have been sanctioned during the preceding year.


(b) *Scope and applicability.* This subpart sets forth—


(1) The policies and procedures that CMS follows to enforce the requirements applicable to laboratories under CLIA and under section 1846 of the Act; and


(2) The appeal rights of laboratories on which CMS imposes sanctions.



---

[N] [57 FR 7237, Feb. 28, 1992, as amended at 79 FR 25480, May 2, 2014]




